A randomized controlled trial of two diets enriched with protein or fat in patients with type 2 diabetes treated with dapagliflozin

Sodium-glucose cotranspsorter-2 (SGLT2) inhibitors (SGLT2i) involve loss of skeletal muscle mass, potentially leading to inadequate HbA1c reduction in type 2 diabetes (T2DM), since muscle mass is related to insulin sensitivity. The benefit of protein-enriched diet for improving HbA1c in SGLT2i-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Yasuhiro, Suzuki, Daisuke, Kuribayashi, Nobuichi, Uchida, Daigaku, Kato, Mitsutoshi, Ohashi, Hiroshi, Nagayama, Daiji, Yamaguchi, Takashi, Ohira, Masahiro, Saiki, Atsuhito, Tatsuno, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166978/
https://www.ncbi.nlm.nih.gov/pubmed/34059720
http://dx.doi.org/10.1038/s41598-021-90879-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166978/
https://www.ncbi.nlm.nih.gov/pubmed/34059720
http://dx.doi.org/10.1038/s41598-021-90879-z

Ejemplares similares